Drug intelligence / Profile preview

Gam-COVID-Vac (Gamaleya Center)

Development stage
Unknown
Lead developer
Gamaleya Center
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

**Gam-COVID-Vac** is a two-component heterologous recombinant adenoviral-vector vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology for prevention of COVID-19. Component I uses recombinant adenovirus type 26 and Component II uses recombinant adenovirus type 5; both vectors encode the full-length SARS-CoV-2 spike glycoprotein. Intramuscular prime-boost administration induces humoral and cellular immune responses directed against spike, supporting protection against SARS-CoV-2 infection and COVID-19. The vaccine is marketed as Sputnik V and was registered by the Russian Ministry of Health in August 2020; an interim Phase 3 analysis reported 91.6% efficacy against symptomatic COVID-19. ([thelancet.com](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900234-8/fulltext))

Brand names
Sputnik V
Other names
GamCovidVac
02

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on Gam-COVID-Vac (Gamaleya Center).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gam-COVID-Vac (Gamaleya Center).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call